Thomas A. Rayski

Thomas A. Rayski works with clients to structure and negotiate complex domestic and foreign transactions involving intellectual property and technology assets, including strategic collaborations, acquisitions, licenses, research and development arrangements, joint ventures, financings and manufacturing and distribution agreements. Mr. Rayski also advises clients on the protection, management and enforcement of their patents, trademarks, copyrights and trade secrets, including in establishing and improving policies respecting the identification and development of intellectual property assets.

Mr. Rayski advises clients in the life sciences industry in complex collaborations and licensing transactions, including platform and drug discovery collaborations and early and late-stage product deals, on behalf of both licensors and licensees. In addition, Mr. Rayski has broad experience in negotiating development agreements, sponsored research agreements, university licenses and distribution and supply arrangements involving pharmaceutical compounds, biologics and medical devices. 

Mr. Rayski also counsels established and start-up companies in the financial services and information technology industries with respect to a diverse range of matters, including software development and licensing, online agreements, service agreements and data privacy. He also advises on the intellectual property and technology aspects of corporate transactions such as mergers, acquisitions, spin-outs and equity investments.

In 2023, he was recognized as a leading practitioner in New York by IAM Patent 1000, “thanks to his impressive work in the transactional space.”

Prior to beginning his legal career, Mr. Rayski worked as a systems engineer for Electronic Data Systems and was responsible for the development, implementation, and support of custom-developed computer systems for customers in the manufacturing industry.